China patent law and implications for international pharmaceutical companies

被引：3

|

作者：

Deng, Michelle M. ^{[1
]}

机构：

[1] Genzyme Corp, 500 Kendall St, Cambridge, MA 02142 USA

来源：

EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2010年 / 3卷 / 06期

关键词：

biotechnology; China; patent law; patent law amendment; patent rights; pharmaceutical;

D O I：

10.1586/ECP.10.54

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：713 / 716

页数：4

相关论文

共 50 条

[21] The Unitary Patent and UPC - Implications for the pharmaceutical sector
Mummery, Zack
DRUG DISCOVERY TODAY, 2022, 27 (12)
[22] Patent law harmonization and international trade
Ito, Banri
Shirai, Katsunori
INTERNATIONAL JOURNAL OF ECONOMIC POLICY STUDIES, 2023, 17 (01) : 289 - 306
[23] Developments in international patent law harmonization
Baechtold, P
CHIMIA, 2000, 54 (05) : 288 - 290
[24] Patent Application, Grant and Patent Law Amendment in China
Gupeng Zhang
Sen Du
Mengya Zhang
Innovation and Development Policy, 2020, 2 (02) : 126 - 137
[25] Evaluating Flexibility in International Patent Law
Rajec, Sarah R. Wasserman
HASTINGS LAW JOURNAL, 2013, 65 (01) : 153 - 209
[26] The international patent law's development
Uemura, S.
2001, Editorial Board of Intelektual'naya Sobstvennost'
[27] Patent law harmonization and international trade
Banri Ito
Katsunori Shirai
International Journal of Economic Policy Studies, 2023, 17 : 289 - 306
[28] CHINA AND INTERNATIONAL-LAW - IMPLICATIONS FOR FOREIGN-POLICY
OGDEN, S
PACIFIC AFFAIRS, 1976, 49 (01) : 28 - 48
[29] Enforcing pharmaceutical and biotech patent rights in China
Zhang, Y. Philip
Deng, Michelle M.
NATURE BIOTECHNOLOGY, 2008, 26 (11) : 1235 - 1241
[30] Enforcing pharmaceutical and biotech patent rights in China
Y Philip Zhang
Michelle M Deng
Nature Biotechnology, 2008, 26 : 1235 - 1240

← 1 2 3 4 5 →